Sorting Out the Stats from the Jaks
The 20th anniversary of a landmark scientific discovery provides
an opportunity to look into the future of ocular therapies.
Medical Device Regulation: A Review
Business of retina clinical trials for the retina specialist
Begin with the End in Mind
Ophthalmic Product Development Insights
The Drug Development Path
Business of retina clinical trials for the retina specialist
2012: Completing the premium surgical suite picture
Technologies such as femtosecond lasers, OVDs optimize patient satisfaction, outcomes
2012: Year for retina approvals
Advances include treatments for CRVO, DME , VMA; many prospects in pipeline
Where Are We With Therapeutic Approaches for Retinal Vascular Diseases?
One Year After Aflibercept
Adopting and Adapting Imaging Tools for Clinical Use
Imaging advances are providing entirely new ways of capturing the human eye and visualizing ocular structures and disorders.
Ora in India
Ocular therapeutics is a global business so it’s no surprise that current Ora projects include studies around the world.
Clinical Trials from the Statistician’s Side: Reducing Variability
When minimizing variability in retinal imaging data for a clinical trial, there exists a “uniform operations chain” consisting of the machine, operator, and reading center.